Maria Cristina Sauerland

Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

Hubert Serve, Utz Krug, Ruth Wagner et al. · Journal of Clinical Oncology · 2013 · 309 citations · Full text

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Utz Krug, Christoph Röllig, Anja Koschmieder et al. · The Lancet · 2010 · 302 citations

Hematological Malignancy, Prognostic Evaluation, Medicine +12

Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) Is Related to Unfavorable Cytogenetics but Has No Independent Prognostic Relevance Under the Conditions of Intensive Induction Therapy: Results of a Multiparameter Analysis From the German AML Cooperative Group Studies

Torsten Haferlach, Claudia Schoch, Helmut Löffler et al. · Journal of Clinical Oncology · 2003 · 188 citations

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Tobias Herold, Maja Rothenberg‐Thurley, Victoria V. Grunwald et al. · Leukemia · 2020 · 184 citations · Full text

Patients with <i>de novo</i> acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

Claudia Schoch, Torsten Haferlach, Detlef Haase et al. · British Journal of Haematology · 2001 · 178 citations · Full text